To test whether depletion of FBXO22 affected cell motility by regulating FoxO1 in osteosarcoma cells, we performed Transwell migration and invasion assays in U2OS and SaOS‐2 cells after shFBXO22 transfection in combination with shFoxO1 treatment. This evidence concerns the gene FBXO22 and osteosarcoma.